GAL3+ disease-associated microglia abundance

There is 1 paper on GAL3+ disease-associated microglia abundance in aging research: none in people yet, 1 in animals.

Biomarker

1 paper studies it2 findings

See all 1 papers on GAL3+ disease-associated microglia abundance

  • Animals1

Upstream

2

BCL2

upin mice1

1 study
  1. BCL2 increases GAL3+ disease-associated microglia abundance in mice (shown by pharmacological targeting of BCL2).

    “Pharmacogenetic or pharmacological targeting of p16ink4a or BCL2 reduced white matter GAL3+ DAM abundance and rejuvenated microglial fimbria organization.”

    Animalsshown by pharmacological targeting of BCL2white matter

    Senescent and disease-associated microglia are modifiable features of aged brain white matter

    Research squarePreprint

More on BCL2

CDKN2A

upin mice1

1 study
  1. CDKN2A increases GAL3+ disease-associated microglia abundance in mice (shown by pharmacogenetic targeting of p16ink4a).

    “Pharmacogenetic or pharmacological targeting of p16ink4a or BCL2 reduced white matter GAL3+ DAM abundance and rejuvenated microglial fimbria organization.”

    Animalsshown by pharmacogenetic targeting of p16ink4awhite matter

    Senescent and disease-associated microglia are modifiable features of aged brain white matter

    Research squarePreprint

More on CDKN2A

Latest